During the past decade, ARENSIA Exploratory Medicine Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ARENSIA Exploratory Medicine Unit" are "Prostatic Neoplasms" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "ARENSIA Exploratory Medicine Unit" in a lesser frequency.

Most popular intervention types in "ARENSIA Exploratory Medicine Unit" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone Acetate (AA)" (1 trials), "JNJ-67484703" (1 trials), "Niraparib" (1 trials), "Placebo" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "ARENSIA Exploratory Medicine Unit" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "ARENSIA Exploratory Medicine Unit". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in ARENSIA Exploratory Medicine Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ARENSIA Exploratory Medicine Unit, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".